The Administration of 4-Hexylresorcinol Accelerates Orthodontic Tooth Movement and Increases the Expression Level of Bone Turnover Markers in Ovariectomized Rats.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
24 Feb 2020
Historique:
received: 04 02 2020
revised: 20 02 2020
accepted: 21 02 2020
entrez: 28 2 2020
pubmed: 28 2 2020
medline: 24 11 2020
Statut: epublish

Résumé

Surgical methods for accelerating orthodontic tooth movement are limited by possible damage to the tooth root and patient discomfort. 4-Hexylresorcinol (4HR) has been shown to increase bone remodeling and may potentially facilitate tooth movement. This study investigated the (1) effect of 4HR administration on osteoblast-like cells and (2) effect of 4HR administration on tooth movement in ovariectomized rats. Saos-2 cells were treated with either 4HR or solvent (control). Protein expression levels were investigated 2, 8, and 24 h after treatment. Thirty ovariectomized Sprague-Dawley rats were divided into two experimental groups (A and B) and one control group. After installation of an orthodontic tooth movement device, groups A and B received subcutaneous weekly injections of 4HR (1.28 and 128 mg/kg). Micro-computerized tomography and histological analyses were performed after 2 weeks of tooth movement. The application of 4HR elevated expression of osteogenic markers in Saos-2 cells. Movement of the first molars was significantly greater in rats administered 4HR. Furthermore, the expression of bone morphogenic protein-2, receptor activator of nuclear factor kappa-B ligand, osteocalcin, and tartrate-resistant acid phosphatase were increased after 4HR administration. 4HR application demonstrated increased expression of osteogenic markers in Saos-2 cells and accelerated orthodontic tooth movement in rats.

Identifiants

pubmed: 32102282
pii: ijms21041526
doi: 10.3390/ijms21041526
pmc: PMC7073238
pii:
doi:

Substances chimiques

Biomarkers 0
Transforming Growth Factor beta1 0
Osteocalcin 104982-03-8
Osteopontin 106441-73-0
Hexylresorcinol R9QTB5E82N

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Rural developement administration
ID : PJ01313902

Références

Curr Osteoporos Rep. 2016 Dec;14(6):292-309
pubmed: 27766484
Prog Orthod. 2018 Jun 25;19(1):18
pubmed: 29938297
Am J Orthod Dentofacial Orthop. 2009 Jan;135(1):16-26
pubmed: 19121496
Biochem Pharmacol. 2017 May 15;132:1-8
pubmed: 28189726
Maxillofac Plast Reconstr Surg. 2018 Dec 28;40(1):44
pubmed: 30613574
Am J Orthod Dentofacial Orthop. 2019 Nov;156(5):582-592
pubmed: 31677666
Eur Cell Mater. 2014 Oct 23;28:269-86
pubmed: 25340806
Osteoporos Int. 2009 Jun;20(6):843-51
pubmed: 19190842
Niger J Clin Pract. 2018 Mar;21(3):301-305
pubmed: 29519977
FEBS Open Bio. 2017 Dec 16;8(2):168-176
pubmed: 29435407
Mol Med Rep. 2019 Nov;20(5):4331-4339
pubmed: 31545488
Front Immunol. 2019 Mar 29;10:629
pubmed: 30984193
Am J Orthod Dentofacial Orthop. 2006 Apr;129(4):458-68
pubmed: 16627170
Prog Orthod. 2016 Dec;17(1):33
pubmed: 27696311
Biochem Biophys Res Commun. 2013 Mar 8;432(2):248-55
pubmed: 23402759
Maxillofac Plast Reconstr Surg. 2019 Nov 8;41(1):46
pubmed: 31763327
Am J Orthod Dentofacial Orthop. 2008 Apr;133(4):572-83
pubmed: 18405822
Sci Rep. 2019 Mar 4;9(1):3379
pubmed: 30833641
Ann N Y Acad Sci. 2018 Dec;1433(1):29-40
pubmed: 30091466
Bone. 1996 May;18(5):443-50
pubmed: 8739902
Int J Mol Sci. 2018 Oct 01;19(10):
pubmed: 30275408
Chem Rev. 1999 Jan 13;99(1):1-26
pubmed: 11848979
Am J Orthod Dentofacial Orthop. 2019 May;155(5):670-680
pubmed: 31053283
J Cell Biochem. 2013 May;114(5):975-84
pubmed: 23225263
Angle Orthod. 2012 Jul;82(4):637-44
pubmed: 22214389
J Rheumatol. 2002 May;29(5):990-8
pubmed: 12022363
J Korean Neurosurg Soc. 2012 Jun;51(6):323-7
pubmed: 22949959
Biomaterials. 2014 Oct;35(30):8576-84
pubmed: 25023393
Sci Rep. 2019 Mar 5;9(1):3448
pubmed: 30837602
J Oral Maxillofac Surg. 2011 Nov;69(11):e354-63
pubmed: 21821331
Arthritis Rheum. 1998 Feb;41(2):274-83
pubmed: 9485085
Endocrinology. 1973 Nov;93(5):1057-65
pubmed: 4778754
Int J Mol Sci. 2019 Oct 04;20(19):
pubmed: 31590328
Am J Orthod Dentofacial Orthop. 2011 Apr;139(4):e337-44
pubmed: 21457840
Orthod Craniofac Res. 2019 Feb;22(1):16-23
pubmed: 30449070
Angle Orthod. 1998 Apr;68(2):161-5
pubmed: 9564426
Ann Clin Biochem. 2018 May;55(3):308-327
pubmed: 29368538
Chirurgia (Bucur). 2017 Jul-Aug;112(4):413-417
pubmed: 28862117
Angle Orthod. 2011 Jul;81(4):570-7
pubmed: 21361777
Am J Orthod Dentofacial Orthop. 2007 Apr;131(4):448.e1-8
pubmed: 17418709
J Craniofac Surg. 2018 Oct;29(7):1983-1990
pubmed: 29561490
J Drugs Dermatol. 2016 Jul 1;15(7):863-8
pubmed: 27391637
Maxillofac Plast Reconstr Surg. 2018 Nov 22;40(1):34
pubmed: 30525010

Auteurs

Kwang-Hyo Choi (KH)

Department of Orthodontics, College of Dentistry, Seoul National University, Seoul 3080, Korea.

Dae-Won Kim (DW)

Department of Oral Biochemistry, College of Dentistry, Gangneung-Wonju National University, Gangneung 28644, Korea.

Suk Keun Lee (SK)

Department of Oral Pathology, College of Dentistry, Gangneung-Wonju National University, and Institute of Oral Science, Gangneung 28644, Korea.

Seong-Gon Kim (SG)

Department of Oral and Maxillofacial Surgery, College of Dentistry, Gangneung-Wonju National University, Gangneung 28644, Korea.

Tae-Woo Kim (TW)

Department of Orthodontics, College of Dentistry, Seoul National University, Seoul 3080, Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH